Zschaeck Sebastian, Weingärtner Julian, Lombardo Elia, Marschner Sebastian, Hajiyianni Marina, Beck Marcus, Zips Daniel, Li Yimin, Lin Qin, Amthauer Holger, Troost Esther G C, van den Hoff Jörg, Budach Volker, Kotzerke Jörg, Ferentinos Konstantinos, Karagiannis Efstratios, Kaul David, Gregoire Vincent, Holzgreve Adrien, Albert Nathalie L, Nikulin Pavel, Bachmann Michael, Kopka Klaus, Krause Mechthild, Baumann Michael, Kazmierska Joanna, Cegla Paulina, Cholewinski Witold, Strouthos Iosif, Zöphel Klaus, Majchrzak Ewa, Landry Guillaume, Belka Claus, Stromberger Carmen, Hofheinz Frank
Department of Radiation Oncology, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
Front Oncol. 2022 Jun 8;12:870319. doi: 10.3389/fonc.2022.870319. eCollection 2022.
18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is utilized for staging and treatment planning of head and neck squamous cell carcinomas (HNSCC). Some older publications on the prognostic relevance showed inconclusive results, most probably due to small study sizes. This study evaluates the prognostic and potentially predictive value of FDG-PET in a large multi-center analysis.
Original analysis of individual FDG-PET and patient data from 16 international centers (8 institutional datasets, 8 public repositories) with 1104 patients. All patients received curative intent radiotherapy/chemoradiation (CRT) and pre-treatment FDG-PET imaging. Primary tumors were semi-automatically delineated for calculation of SUV, SUV, metabolic tumor volume (MTV) and total lesion glycolysis (TLG). Cox regression analyses were performed for event-free survival (EFS), overall survival (OS), loco-regional control (LRC) and freedom from distant metastases (FFDM).
FDG-PET parameters were associated with patient outcome in the whole cohort regarding clinical endpoints (EFS, OS, LRC, FFDM), in uni- and multivariate Cox regression analyses. Several previously published cut-off values were successfully validated. Subgroup analyses identified tumor- and human papillomavirus (HPV) specific parameters. In HPV positive oropharynx cancer (OPC) SUV was well suited to identify patients with excellent LRC for organ preservation. Patients with SUV of 14 or less were unlikely to develop loco-regional recurrence after definitive CRT. In contrast FDG PET parameters deliver only limited prognostic information in laryngeal cancer.
FDG-PET parameters bear considerable prognostic value in HNSCC and potential predictive value in subgroups of patients, especially regarding treatment de-intensification and organ-preservation. The potential predictive value needs further validation in appropriate control groups. Further research on advanced imaging approaches including radiomics or artificial intelligence methods should implement the identified cut-off values as benchmark routine imaging parameters.
18F-氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)用于头颈部鳞状细胞癌(HNSCC)的分期和治疗计划制定。一些关于预后相关性的早期出版物结果不明确,很可能是由于研究规模较小。本研究在一项大型多中心分析中评估FDG-PET的预后和潜在预测价值。
对来自16个国际中心(8个机构数据集、8个公共数据库)的1104例患者的个体FDG-PET和患者数据进行原始分析。所有患者均接受了根治性放疗/放化疗(CRT)及治疗前FDG-PET成像。对原发性肿瘤进行半自动勾画,以计算SUV、SUV、代谢肿瘤体积(MTV)和总病变糖酵解(TLG)。对无事件生存期(EFS)、总生存期(OS)、局部区域控制(LRC)和无远处转移生存期(FFDM)进行Cox回归分析。
在单因素和多因素Cox回归分析中,FDG-PET参数与整个队列中关于临床终点(EFS、OS、LRC、FFDM)的患者预后相关。几个先前公布的临界值得到了成功验证。亚组分析确定了肿瘤和人乳头瘤病毒(HPV)特异性参数。在HPV阳性口咽癌(OPC)中,SUV非常适合识别具有良好LRC以保留器官的患者。SUV为14或更低的患者在确定性CRT后不太可能发生局部区域复发。相比之下,FDG PET参数在喉癌中仅提供有限的预后信息。
FDG-PET参数在HNSCC中具有相当大的预后价值,在患者亚组中具有潜在的预测价值,尤其是在治疗降阶梯和器官保留方面。潜在的预测价值需要在适当的对照组中进一步验证。对包括放射组学或人工智能方法在内的先进成像方法的进一步研究应将确定的临界值作为基准常规成像参数。